L2 Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
L2 Asset Management's EW Position: Q2 2026 in Review
L2 Asset Management reduced its Edwards Lifesciences (EW) stake by 0.83% in Q2 2026, selling an estimated $2.43K and leaving 3,479 shares worth $315K. The position accounts for 0.03% of the portfolio, ranked #338.
L2 Asset Management first reported a position in EW in Q2 2024 and has held it in 6 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- L2 Asset Management held 3,479 shares of Edwards Lifesciences worth $315K as of Q2 2026.
- L2 Asset Management sold 29 Edwards Lifesciences shares in Q2 2026, an estimated $2.43K.
- Edwards Lifesciences made up 0.03% of L2 Asset Management's portfolio in Q2 2026, its #338 holding.
- L2 Asset Management first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 6 quarters since.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.